Evidence map›Paper›PMID 25035428›Full record

ArticleThe Journal of biological chemistry2014

Structural determinants of the transient receptor potential 1 (TRPV1) channel activation by phospholipid analogs.

Sara L Morales-Lázaro, Barbara Serrano-Flores, Itzel Llorente, Enrique Hernández-García, Ricardo González-Ramírez, Souvik Banerjee, Duane Miller, Veeresh Gududuru, James Fells, Derek Norman and 3 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. TRPV1: Structure, Endogenous Agonists, and Mechanisms.International journal of molecular sciences · 2020
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Regulation of thermoTRPs by lipids.Temperature (Austin, Tex.) · 2017
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Sara L Morales-LázaroFrom the Departamento de Neurodesarrollo y Fisiología, División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México D.F. 04510, México.
Barbara Serrano-FloresFrom the Departamento de Neurodesarrollo y Fisiología, División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México D.F. 04510, México.
Itzel LlorenteFrom the Departamento de Neurodesarrollo y Fisiología, División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México D.F. 04510, México.
Enrique Hernández-GarcíaFrom the Departamento de Neurodesarrollo y Fisiología, División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México D.F. 04510, México.
Ricardo González-Ramírezthe Departmento de Biología Molecular e Histocompatibilidad, Hospital General "Dr. Manuel Gea González", México, D.F. 14080, México.
Souvik Banerjeethe Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Duane Millerthe Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Veeresh GududuruRxBio Inc., Memphis, Tennessee 38163, and.
James Fellsthe Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Derek Normanthe Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Gabor Tigyithe Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Diana Escalante-AlcaldeFrom the Departamento de Neurodesarrollo y Fisiología, División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México D.F. 04510, México.
Tamara RosenbaumFrom the Departamento de Neurodesarrollo y Fisiología, División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México D.F. 04510, México, trosenba@ifc.unam.mx.
Universidad Nacional Autónoma de México · MXRxBio (United States) · US

Funding

Ligand Recognition by Phospholipid Growth Factor ReceptorsR01CA092160 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI TIGYI, GABOR J · 2001 to 2022
$5.9M
IND-Enabling Preclinical Development of a New RadiomitigatorU01AI107331 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI TIGYI, GABOR J · 2013 to 2018
$2.9M
NCI NIH HHS CA-092160NCI NIH HHS R01 CA092160NIAID NIH HHS U01 AI107331
6 · The paper itself

Abstract

The transient receptor potential vanilloid 1 (TRPV1) ion channel is a polymodal protein that responds to various stimuli, including capsaicin (the pungent compound found in chili peppers), extracellular acid, and basic intracellular pH, temperatures close to 42 °C, and several lipids. Lysophosphatidic acid (LPA), an endogenous lipid widely associated with neuropathic pain, is an agonist of the TRPV1 channel found in primary afferent nociceptors and is activated by other noxious stimuli. Agonists or antagonists of lipid and other chemical natures are known to possess specific structural requirements for producing functional effects on their targets. To better understand how LPA and other lipid analogs might interact and affect the function of TRPV1, we set out to determine the structural features of these lipids that result in the activation of TRPV1. By changing the acyl chain length, saturation, and headgroup of these LPA analogs, we established strict requirements for activation of TRPV1. Among the natural LPA analogs, we found that only LPA 18:1, alkylglycerophosphate 18:1, and cyclic phosphatidic acid 18:1, all with a monounsaturated C18 hydrocarbon chain activate TRPV1, whereas polyunsaturated and saturated analogs do not. Thus, TRPV1 shows a more restricted ligand specificity compared with LPA G-protein-coupled receptors. We synthesized fatty alcohol phosphates and thiophosphates and found that many of them with a single double bond in position Δ9, 10, or 11 and Δ9 cyclopropyl group can activate TRPV1 with efficacy similar to capsaicin. Finally, we developed a pharmacophore and proposed a mechanistic model for how these lipids could induce a conformational change that activates TRPV1.

Indexed as

HEK293 CellsHumansLysophospholipidsModels, MolecularProtein ConformationTRPV Cation Channelslysophosphatidic acidLysophospholipidsTRPV1 protein, humanTRPV Cation ChannelsIon ChannelLysophospholipidMembrane LipidPhysiologyTransient Receptor Potential Channels (TRP Channels)

Identifiers

PMID25035428
PMCPMC4148841
OpenAlexW2006662870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.